Chief Medical Officer, Dr. Colin Hayward, Discussion with Wilsons Advisory

20 May 2022 – Clinical Spotlight | Telix Chief Medical Officer, Dr. Colin Hayward, was hosted this week by Shane Storey, Senior Research Analyst at Wilsons Advisory and Stockbroking Limited, to discuss R&D insights across Telix’s imaging and therapeutic research pipeline.

Telix Chief Medical Officer, Dr. Colin Hayward, was hosted this week by Shane Storey, Senior Research Analyst at Wilsons Advisory and Stockbroking Limited, to discuss R&D insights across Telix’s imaging and therapeutic research pipeline.

Topics included:

  1. the future for PSMA-PET imaging
  2. carbonic anhydrase IX (CA9) imaging and therapy
  3. prostate cancer therapy